APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Targeted RNA Sequencing

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

In the report, we only collect information about the companies who can provide targeted RNA sequencing service.

Selected research

Market Structure

Global Targeted RNA Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174039810321 December 2025187 pages

Choose your research edition.

Industry ResearchTargeted RNA Sequencing Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Targeted RNA Sequencing Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Targeted RNA Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Targeted RNA Sequencing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Targeted RNA Sequencing Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

In the report, we only collect information about the companies who can provide targeted RNA sequencing service.

Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.

Report Includes

This report provides an overview of the global Targeted RNA Sequencing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Targeted RNA Sequencing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Targeted RNA Sequencing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Targeted RNA Sequencing market size, projected growth trends, production technologies, key applications, and end-use industries.

Targeted RNA Sequencing Segment by Company

Thermo Fisher

Illumina

Roche Holdings

BGI

Eurofins

LabCorp

Berry Genomics

Macrogen

GENEWIZ

Targeted RNA Sequencing Segment by Type

Exome Sequencing

Enrichment Sequencing

Amplicon Sequencing

Targeted RNA Sequencing Segment by Application

Research Institutes

Hospitals & Clinics

Biotechnology Company

Diagnostic Lab

Targeted RNA Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted RNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Targeted RNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted RNA Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Targeted RNA Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Targeted RNA Sequencing industry.

Chapter 3: Detailed analysis of Targeted RNA Sequencing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted RNA Sequencingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Targeted RNA Sequencing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Exome Sequencing Table 3. Key Players of Enrichment Sequencing Table 4. Key Players of Amplicon Sequencing Table 4. Global Targeted RNA Sequencing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Research Institutes Table 6. Key Players of Hospitals & Clinics Table 7. Key Players of Biotechnology Company Table 8. Key Players of Diagnostic Lab Table 9. Global Targeted RNA Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Targeted RNA Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Targeted RNA Sequencing Market Share by Region (2021-2026) Table 12. Global Targeted RNA Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Targeted RNA Sequencing Market Share by Region (2027-2032) Table 14. Targeted RNA Sequencing Industry Trends Table 15. Targeted RNA Sequencing Industry Drivers Table 16. Targeted RNA Sequencing Industry Opportunities and Challenges Table 17. Targeted RNA Sequencing Industry Restraints Table 18. Global Targeted RNA Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Targeted RNA Sequencing Revenue Market Share by Company (2021-2026) Table 20. Global Targeted RNA Sequencing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Targeted RNA Sequencing Key Company Head Office and Area Served Table 22. Global Targeted RNA Sequencing Company, Product Type & Application Table 23. Global Targeted RNA Sequencing Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Targeted RNA Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Targeted RNA Sequencing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Targeted RNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Targeted RNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Targeted RNA Sequencing Revenue Market Share by Type (2021-2026) Table 30. Global Targeted RNA Sequencing Revenue Market Share by Type (2027-2032) Table 31. Global Targeted RNA Sequencing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Targeted RNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Targeted RNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Targeted RNA Sequencing Revenue Market Share by Application (2021-2026) Table 35. Global Targeted RNA Sequencing Revenue Market Share by Application (2027-2032) Table 36. Thermo Fisher Company Information Table 37. Thermo Fisher Business Overview Table 38. Thermo Fisher Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Thermo Fisher Targeted RNA Sequencing Product Portfolio Table 40. Thermo Fisher Recent Development Table 41. Illumina Company Information Table 42. Illumina Business Overview Table 43. Illumina Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Illumina Targeted RNA Sequencing Product Portfolio Table 45. Illumina Recent Development Table 46. Roche Holdings Company Information Table 47. Roche Holdings Business Overview Table 48. Roche Holdings Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Roche Holdings Targeted RNA Sequencing Product Portfolio Table 50. Roche Holdings Recent Development Table 51. BGI Company Information Table 52. BGI Business Overview Table 53. BGI Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. BGI Targeted RNA Sequencing Product Portfolio Table 55. BGI Recent Development Table 56. Eurofins Company Information Table 57. Eurofins Business Overview Table 58. Eurofins Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Eurofins Targeted RNA Sequencing Product Portfolio Table 60. Eurofins Recent Development Table 61. LabCorp Company Information Table 62. LabCorp Business Overview Table 63. LabCorp Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. LabCorp Targeted RNA Sequencing Product Portfolio Table 65. LabCorp Recent Development Table 66. Berry Genomics Company Information Table 67. Berry Genomics Business Overview Table 68. Berry Genomics Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Berry Genomics Targeted RNA Sequencing Product Portfolio Table 70. Berry Genomics Recent Development Table 71. Macrogen Company Information Table 72. Macrogen Business Overview Table 73. Macrogen Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Macrogen Targeted RNA Sequencing Product Portfolio Table 75. Macrogen Recent Development Table 76. GENEWIZ Company Information Table 77. GENEWIZ Business Overview Table 78. GENEWIZ Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. GENEWIZ Targeted RNA Sequencing Product Portfolio Table 80. GENEWIZ Recent Development Table 81. North America Targeted RNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 82. North America Targeted RNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 83. North America Targeted RNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 84. North America Targeted RNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 85. North America Targeted RNA Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Targeted RNA Sequencing Market Size by Country (2021-2026) Table 87. North America Targeted RNA Sequencing Market Size by Country (2027-2032) Table 88. Europe Targeted RNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 89. Europe Targeted RNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 90. Europe Targeted RNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 91. Europe Targeted RNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 92. Europe Targeted RNA Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Targeted RNA Sequencing Market Size by Country (2021-2026) Table 94. Europe Targeted RNA Sequencing Market Size by Country (2027-2032) Table 95. China Targeted RNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 96. China Targeted RNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 97. China Targeted RNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 98. China Targeted RNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Targeted RNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 100. Asia Targeted RNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 101. Asia Targeted RNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 102. Asia Targeted RNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Targeted RNA Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Targeted RNA Sequencing Market Size by Country (2021-2026) Table 105. Asia Targeted RNA Sequencing Market Size by Country (2027-2032) Table 106. South America, Middle East & Africa Targeted RNA Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 107. South America, Middle East & Africa Targeted RNA Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 108. South America, Middle East & Africa Targeted RNA Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 109. South America, Middle East & Africa Targeted RNA Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 110. South America, Middle East & Africa Targeted RNA Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. South America, Middle East & Africa Targeted RNA Sequencing Market Size by Country (2021-2026) Table 112. South America, Middle East & Africa Targeted RNA Sequencing Market Size by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Targeted RNA Sequencing Product Image Figure 2. Global Targeted RNA Sequencing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Targeted RNA Sequencing Market Share by Type: 2025 VS 2032 Figure 4. Exome Sequencing Image Figure 5. Enrichment Sequencing Image Figure 6. Amplicon Sequencing Image Figure 7. Global Targeted RNA Sequencing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Targeted RNA Sequencing Market Share by Application: 2025 VS 2032 Figure 9. Research Institutes Image Figure 10. Hospitals & Clinics Image Figure 11. Biotechnology Company Image Figure 12. Diagnostic Lab Image Figure 13. Global Targeted RNA Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 15. Global Targeted RNA Sequencing Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Targeted RNA Sequencing Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Targeted RNA Sequencing Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Targeted RNA Sequencing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Targeted RNA Sequencing Revenue Market Share by Type (2021-2032) Figure 22. Global Targeted RNA Sequencing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Targeted RNA Sequencing Revenue Market Share by Application (2021-2032) Figure 24. North America Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 25. North America Targeted RNA Sequencing Market Share by Type (2021-2032) Figure 26. North America Targeted RNA Sequencing Market Share by Application (2021-2032) Figure 27. North America Targeted RNA Sequencing Market Share by Country (2021-2032) Figure 28. United States Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 29. Canada Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 31. Europe Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 32. Europe Targeted RNA Sequencing Market Share by Type (2021-2032) Figure 33. Europe Targeted RNA Sequencing Market Share by Application (2021-2032) Figure 34. Europe Targeted RNA Sequencing Market Share by Country (2021-2032) Figure 35. Germany Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 36. France Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 38. Italy Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 39. Russia Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 41. China Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 42. China Targeted RNA Sequencing Market Share by Type (2021-2032) Figure 43. China Targeted RNA Sequencing Market Share by Application (2021-2032) Figure 44. Asia Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 45. Asia Targeted RNA Sequencing Market Share by Type (2021-2032) Figure 46. Asia Targeted RNA Sequencing Market Share by Application (2021-2032) Figure 47. Asia Targeted RNA Sequencing Market Share by Country (2021-2032) Figure 48. Japan Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 52. India Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 53. Australia Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Targeted RNA Sequencing Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Targeted RNA Sequencing Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Targeted RNA Sequencing Market Share by Country (2021-2032) Figure 58. Brazil Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 63. UAE Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 65. Chile Targeted RNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Exome Sequencing
  • Enrichment Sequencing
  • Amplicon Sequencing
Applications
  • Research Institutes
  • Hospitals & Clinics
  • Biotechnology Company
  • Diagnostic Lab
Companies covered
  • Thermo Fisher
  • Illumina
  • Roche Holdings
  • BGI
  • Eurofins
  • LabCorp
  • Berry Genomics
  • Macrogen
  • GENEWIZ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Targeted RNA Sequencing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Exome Sequencing
  5. 1.2.3 Enrichment Sequencing
  6. 1.2.4 Amplicon Sequencing
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Targeted RNA Sequencing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Research Institutes
  10. 1.3.3 Hospitals & Clinics
  11. 1.3.4 Biotechnology Company
  12. 1.3.5 Diagnostic Lab
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Targeted RNA Sequencing Growth Trends by Region
  15. 1.5.1 Global Targeted RNA Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Targeted RNA Sequencing Market Size by Region (2021-2026)
  17. 1.5.3 Targeted RNA Sequencing Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Targeted RNA Sequencing Market Dynamics
  1. 2.1 Targeted RNA Sequencing Industry Trends
  2. 2.2 Targeted RNA Sequencing Industry Drivers
  3. 2.3 Targeted RNA Sequencing Industry Opportunities and Challenges
  4. 2.4 Targeted RNA Sequencing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Targeted RNA Sequencing Revenue by Company (2021-2026)
  2. 3.2 Global Targeted RNA Sequencing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Targeted RNA Sequencing Key Company Head office and Area Served
  4. 3.4 Global Targeted RNA Sequencing Company, Product Type & Application
  5. 3.5 Global Targeted RNA Sequencing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Targeted RNA Sequencing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Targeted RNA Sequencing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Targeted RNA Sequencing Tier 1, Tier 2, and Tier 3
4 Targeted RNA Sequencing Market by Type
  1. 4.1 Global Targeted RNA Sequencing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Targeted RNA Sequencing Market Size by Type (2021-2032)
  3. 4.3 Global Targeted RNA Sequencing Market Size Share by Type (2021-2032)
5 Targeted RNA Sequencing Market by Application
  1. 5.1 Global Targeted RNA Sequencing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Targeted RNA Sequencing Market Size by Application (2021-2032)
  3. 5.3 Global Targeted RNA Sequencing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Thermo Fisher
  2. 6.1.1 Thermo Fisher Company Information
  3. 6.1.2 Thermo Fisher Business Overview
  4. 6.1.3 Thermo Fisher Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Thermo Fisher Targeted RNA Sequencing Product Portfolio
  6. 6.1.5 Thermo Fisher Recent Developments
  7. 6.2 Illumina
  8. 6.2.1 Illumina Company Information
  9. 6.2.2 Illumina Business Overview
  10. 6.2.3 Illumina Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Illumina Targeted RNA Sequencing Product Portfolio
  12. 6.2.5 Illumina Recent Developments
  13. 6.3 Roche Holdings
  14. 6.3.1 Roche Holdings Company Information
  15. 6.3.2 Roche Holdings Business Overview
  16. 6.3.3 Roche Holdings Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Roche Holdings Targeted RNA Sequencing Product Portfolio
  18. 6.3.5 Roche Holdings Recent Developments
  19. 6.4 BGI
  20. 6.4.1 BGI Company Information
  21. 6.4.2 BGI Business Overview
  22. 6.4.3 BGI Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BGI Targeted RNA Sequencing Product Portfolio
  24. 6.4.5 BGI Recent Developments
  25. 6.5 Eurofins
  26. 6.5.1 Eurofins Company Information
  27. 6.5.2 Eurofins Business Overview
  28. 6.5.3 Eurofins Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Eurofins Targeted RNA Sequencing Product Portfolio
  30. 6.5.5 Eurofins Recent Developments
  31. 6.6 LabCorp
  32. 6.6.1 LabCorp Company Information
  33. 6.6.2 LabCorp Business Overview
  34. 6.6.3 LabCorp Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 LabCorp Targeted RNA Sequencing Product Portfolio
  36. 6.6.5 LabCorp Recent Developments
  37. 6.7 Berry Genomics
  38. 6.7.1 Berry Genomics Company Information
  39. 6.7.2 Berry Genomics Business Overview
  40. 6.7.3 Berry Genomics Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Berry Genomics Targeted RNA Sequencing Product Portfolio
  42. 6.7.5 Berry Genomics Recent Developments
  43. 6.8 Macrogen
  44. 6.8.1 Macrogen Company Information
  45. 6.8.2 Macrogen Business Overview
  46. 6.8.3 Macrogen Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Macrogen Targeted RNA Sequencing Product Portfolio
  48. 6.8.5 Macrogen Recent Developments
  49. 6.9 GENEWIZ
  50. 6.9.1 GENEWIZ Company Information
  51. 6.9.2 GENEWIZ Business Overview
  52. 6.9.3 GENEWIZ Targeted RNA Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 GENEWIZ Targeted RNA Sequencing Product Portfolio
  54. 6.9.5 GENEWIZ Recent Developments
7 North America
  1. 7.1 North America Targeted RNA Sequencing Market Size (2021-2032)
  2. 7.2 North America Targeted RNA Sequencing Market Size by Type
  3. 7.2.1 North America Targeted RNA Sequencing Market Size by Type (2021-2026)
  4. 7.2.2 North America Targeted RNA Sequencing Market Size by Type (2027-2032)
  5. 7.2.3 North America Targeted RNA Sequencing Market Share by Type (2021-2032)
  6. 7.3 North America Targeted RNA Sequencing Market Size by Application
  7. 7.3.1 North America Targeted RNA Sequencing Market Size by Application (2021-2026)
  8. 7.3.2 North America Targeted RNA Sequencing Market Size by Application (2027-2032)
  9. 7.3.3 North America Targeted RNA Sequencing Market Share by Application (2021-2032)
  10. 7.4 North America Targeted RNA Sequencing Market Size by Country
  11. 7.4.1 North America Targeted RNA Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Targeted RNA Sequencing Market Size by Country (2021-2026)
  13. 7.4.3 North America Targeted RNA Sequencing Market Size by Country (2027-2032)
  14. 7.4.4 North America Targeted RNA Sequencing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Targeted RNA Sequencing Market Size (2021-2032)
  2. 8.2 Europe Targeted RNA Sequencing Market Size by Type
  3. 8.2.1 Europe Targeted RNA Sequencing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Targeted RNA Sequencing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Targeted RNA Sequencing Market Share by Type (2021-2032)
  6. 8.3 Europe Targeted RNA Sequencing Market Size by Application
  7. 8.3.1 Europe Targeted RNA Sequencing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Targeted RNA Sequencing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Targeted RNA Sequencing Market Share by Application (2021-2032)
  10. 8.4 Europe Targeted RNA Sequencing Market Size by Country
  11. 8.4.1 Europe Targeted RNA Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Targeted RNA Sequencing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Targeted RNA Sequencing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Targeted RNA Sequencing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Targeted RNA Sequencing Market Size (2021-2032)
  2. 9.2 China Targeted RNA Sequencing Market Size by Type
  3. 9.2.1 China Targeted RNA Sequencing Market Size by Type (2021-2026)
  4. 9.2.2 China Targeted RNA Sequencing Market Size by Type (2027-2032)
  5. 9.2.3 China Targeted RNA Sequencing Market Share by Type (2021-2032)
  6. 9.3 China Targeted RNA Sequencing Market Size by Application
  7. 9.3.1 China Targeted RNA Sequencing Market Size by Application (2021-2026)
  8. 9.3.2 China Targeted RNA Sequencing Market Size by Application (2027-2032)
  9. 9.3.3 China Targeted RNA Sequencing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Targeted RNA Sequencing Market Size (2021-2032)
  2. 10.2 Asia Targeted RNA Sequencing Market Size by Type
  3. 10.2.1 Asia Targeted RNA Sequencing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Targeted RNA Sequencing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Targeted RNA Sequencing Market Share by Type (2021-2032)
  6. 10.3 Asia Targeted RNA Sequencing Market Size by Application
  7. 10.3.1 Asia Targeted RNA Sequencing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Targeted RNA Sequencing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Targeted RNA Sequencing Market Share by Application (2021-2032)
  10. 10.4 Asia Targeted RNA Sequencing Market Size by Country
  11. 10.4.1 Asia Targeted RNA Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Targeted RNA Sequencing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Targeted RNA Sequencing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Targeted RNA Sequencing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Targeted RNA Sequencing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Targeted RNA Sequencing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Targeted RNA Sequencing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Targeted RNA Sequencing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Targeted RNA Sequencing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst